Replacement
3rd April 2013
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings - 28 March 2013
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 28 March 2013 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Holdings |
% |
Pfizer |
8.2% |
Merck & Co |
6.6% |
Novartis |
6.6% |
GlaxoSmithKline |
6.4% |
Roche Holding |
5.6% |
AstraZeneca |
5.5% |
Eli Lilly |
4.9% |
Astellas Pharma |
4.0% |
Sanofi |
3.8% |
Takeda Pharmaceutical Company NPV |
3.6% |
Total |
55.2% |
Sector Exposure |
% |
Pharmaceuticals |
67.6% |
Health Care Equipment |
6.7% |
Specialized REITs |
6.9% |
Health Care Facilities |
5.4% |
Health Care Services |
3.3% |
Biotechnology |
4.0% |
Health Care Supplies |
2.0% |
Health Care Distributors |
1.2% |
Health Care Technology |
1.2% |
Life Sciences Tools & Services |
0.8% |
Life & Health Insurance |
0.5% |
Multi-line Insurance |
0.1% |
Cash |
0.3% |
Total |
100.0% |
A copy of the entire portfolio as at 28th of February 2013 will be available to view tomorrow on the Company's website.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.